Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page history adds a new entry for Revision v3.3.2 and removes Revision v3.3.1, reflecting a small metadata update to the version log.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision history shows addition of v3.3.1 and removal of v3.2.0 entries; the visible study details and user-facing content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoval of the old version's government funding and NIH operating status notice from the page. This change does not affect core trial data; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check44 days agoChange DetectedNew screenshot shows an additional version entry in the Study Record History with updated submission dates, while the main content of the page and study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded a government funding lapse notice and updated version to v3.2.0; removed the previous v3.1.0 revision.SummaryDifference9%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.